diff --git a/domains/health/Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md b/domains/health/Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md
index 2f3e3f834..7bb461ae0 100644
--- a/domains/health/Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md	
+++ b/domains/health/Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md	
@@ -23,6 +23,12 @@ Devoted was built from scratch on the Orinoco platform — a unified AI-native o
 
 Since [[proxy inertia is the most reliable predictor of incumbent failure because current profitability rationally discourages pursuit of viable futures]], UnitedHealth's $9 billion annual technology spend directed at optimizing existing infrastructure (consolidating 18 EMRs, AI scribing within legacy workflows) rather than rebuilding around prevention is textbook proxy inertia. The margin from coding arbitrage rationally prevents pursuit of the purpose-built alternative.
 
+
+### Additional Evidence (extend)
+*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
+
+The competitive context for Devoted's 121% growth is now clearer: UnitedHealth Group and Humana control 46% of the MA market (15.6M enrollees), with UHG alone at 29% (9.9M). In 2025, Humana lost 297K members while UHG gained 505K, showing consolidation toward the dominant player rather than competitive redistribution. Devoted's growth is occurring in a market where the top 5 organizations control 70% of enrollment and 815 counties (26% of all counties) have 75%+ concentration in just UHG and Humana. This oligopoly structure makes Devoted's technology-first approach even more significant—it's achieving hypergrowth against entrenched incumbents with massive scale advantages and local market dominance.
+
 ---
 
 Relevant Notes:
diff --git a/domains/health/chronic-condition-special-needs-plans-grew-71-percent-in-one-year-indicating-explosive-demand-for-specialized-disease-management.md b/domains/health/chronic-condition-special-needs-plans-grew-71-percent-in-one-year-indicating-explosive-demand-for-specialized-disease-management.md
new file mode 100644
index 000000000..5240427fe
--- /dev/null
+++ b/domains/health/chronic-condition-special-needs-plans-grew-71-percent-in-one-year-indicating-explosive-demand-for-specialized-disease-management.md
@@ -0,0 +1,35 @@
+---
+type: claim
+domain: health
+description: "C-SNPs experienced 71% growth 2024-2025 while overall MA grew 4%, making chronic disease management the fastest-growing MA segment"
+confidence: proven
+source: "Kaiser Family Foundation, Medicare Advantage in 2025: Enrollment Update and Key Trends"
+created: 2025-07-24
+---
+
+# Chronic-condition Special Needs Plans grew 71 percent in one year indicating explosive demand for specialized disease management
+
+Chronic-condition Special Needs Plans (C-SNPs) grew 71% between 2024 and 2025, reaching 1.2 million enrollees (16% of all SNP enrollment). This growth rate is 18x faster than overall Medicare Advantage growth (4% in the same period) and represents the fastest-growing segment of the MA market.
+
+C-SNPs are MA plans restricted to beneficiaries with specific severe or disabling chronic conditions (diabetes, cardiovascular disorders, chronic heart failure, dementia). The explosive growth indicates that both plans and beneficiaries see value in condition-specific care coordination and management. This aligns with the broader shift toward specialized, high-touch care models for the chronic disease burden that dominates US healthcare spending.
+
+The C-SNP growth trajectory connects to the metabolic disease epidemic and the rising prevalence of treatable but not curable chronic conditions. As chronic conditions become more prevalent and more treatable, the demand for specialized management infrastructure grows. C-SNPs represent the organizational response to this demand—a market correction toward condition-specific care models rather than general-purpose MA plans.
+
+The 71% growth rate is unsustainable long-term but indicates a market correction toward specialization. Traditional MA plans are general-purpose; C-SNPs are specialized. The growth suggests that specialization creates value that beneficiaries and plans both recognize, potentially through better outcomes, lower costs, or both.
+
+## Evidence
+- C-SNP enrollment: 1.2M (2025), representing 16% of all SNP enrollment
+- Growth rate: 71% (2024-2025)
+- Overall MA growth: 4% (same period)
+- C-SNPs are 18x faster growing than overall MA market
+- Total SNP enrollment: 7.3M (21% of MA), up from 14% in 2020
+
+---
+
+Relevant Notes:
+- [[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]
+- [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
+- [[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]
+
+Topics:
+- [[domains/health/_map]]
diff --git a/domains/health/medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-public-to-managed-care.md b/domains/health/medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-public-to-managed-care.md
new file mode 100644
index 000000000..f0b484042
--- /dev/null
+++ b/domains/health/medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-public-to-managed-care.md
@@ -0,0 +1,31 @@
+---
+type: claim
+domain: health
+description: "MA enrollment reached 51% in 2023 and 54% by 2025, crossing the majority threshold and making traditional Medicare the minority program for the first time"
+confidence: proven
+source: "Kaiser Family Foundation, Medicare Advantage in 2025: Enrollment Update and Key Trends"
+created: 2025-07-24
+---
+
+# Medicare Advantage crossed majority enrollment in 2023 marking structural transformation from public to managed care
+
+Medicare Advantage enrollment reached 51% of eligible beneficiaries in 2023, crossing the majority threshold for the first time in the program's history. By 2025, 34.1 million beneficiaries (54% of eligible) were enrolled in MA plans, up from just 19% (7.6M) in 2007. The Congressional Budget Office projects 64% penetration by 2034.
+
+This represents a fundamental structural transformation in American healthcare delivery. Traditional Medicare—the original public insurance program—is now the minority option and trending toward becoming a residual program for those who cannot access or choose not to participate in managed care. The 18-year trajectory from 19% to 54% enrollment shows sustained, accelerating adoption rather than a temporary shift.
+
+The transformation is particularly pronounced in Special Needs Plans (SNPs), which grew from 14% of MA enrollment in 2020 to 21% (7.3M) in 2025. Chronic-condition SNPs (C-SNPs) experienced 71% growth in a single year (2024-2025), indicating that MA is increasingly the delivery mechanism for managing the chronic disease burden that dominates US healthcare spending.
+
+## Evidence
+- KFF enrollment data: 7.6M (19%) in 2007 → 30.8M (51%) in 2023 → 34.1M (54%) in 2025
+- CBO projection: 64% penetration by 2034
+- SNP growth: 14% of MA enrollment (2020) → 21% (2025)
+- C-SNP explosive growth: 71% increase 2024-2025
+
+---
+
+Relevant Notes:
+- [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
+- [[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]
+
+Topics:
+- [[domains/health/_map]]
diff --git a/domains/health/medicare-advantage-market-is-an-oligopoly-with-unitedhealth-and-humana-controlling-46-percent-despite-nominal-plan-choice.md b/domains/health/medicare-advantage-market-is-an-oligopoly-with-unitedhealth-and-humana-controlling-46-percent-despite-nominal-plan-choice.md
new file mode 100644
index 000000000..27603edae
--- /dev/null
+++ b/domains/health/medicare-advantage-market-is-an-oligopoly-with-unitedhealth-and-humana-controlling-46-percent-despite-nominal-plan-choice.md
@@ -0,0 +1,34 @@
+---
+type: claim
+domain: health
+description: "Two companies control 46% of MA enrollment while 815 counties (26% of all counties) have 75%+ concentration, contradicting competitive market assumptions despite nominal plan choice"
+confidence: proven
+source: "Kaiser Family Foundation, Medicare Advantage in 2025: Enrollment Update and Key Trends"
+created: 2025-07-24
+---
+
+# Medicare Advantage market is an oligopoly with UnitedHealth and Humana controlling 46 percent despite nominal plan choice
+
+UnitedHealth Group and Humana together control 46% of the Medicare Advantage market (15.6M of 34.1M enrollees), with UHG alone holding 29% market share (9.9M). In 815 counties—26% of all US counties—these two companies have 75% or greater enrollment concentration. This market structure persists despite beneficiaries having an average of 9 parent organization options, with 36% having 10+ plan choices.
+
+The concentration is increasing, not diversifying. In 2025, Humana lost 297K members while UHG gained 505K, suggesting consolidation toward the dominant player rather than competitive redistribution. The top five organizations (UHG, Humana, CVS/Aetna, Elevance, Kaiser) control 70% of enrollment, leaving only 30% distributed among all other competitors.
+
+This oligopoly structure contradicts the theoretical competitive market that MA plan choice is supposed to create. The presence of multiple plan options does not translate to competitive market dynamics when two companies control nearly half of all enrollment and dominate local markets. The market concentration has significant implications for negotiating power with providers, pricing dynamics, and the viability of new entrants.
+
+## Evidence
+- UHG: 9.9M enrollees (29% market share)
+- Humana: 5.7M enrollees (17% market share)
+- Combined: 15.6M (46% of total MA enrollment)
+- 815 counties (26% of all counties) have 75%+ concentration in UHG + Humana
+- 2025 dynamics: Humana lost 297K members, UHG gained 505K
+- Top 5 organizations control 70% of enrollment
+- Average beneficiary has 9 parent organization options
+
+---
+
+Relevant Notes:
+- [[Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening]]
+- [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
+
+Topics:
+- [[domains/health/_map]]
diff --git a/domains/health/medicare-advantage-spending-gap-grew-4-7x-while-enrollment-doubled-showing-scale-worsens-overpayment-not-improves-it.md b/domains/health/medicare-advantage-spending-gap-grew-4-7x-while-enrollment-doubled-showing-scale-worsens-overpayment-not-improves-it.md
new file mode 100644
index 000000000..3060980d9
--- /dev/null
+++ b/domains/health/medicare-advantage-spending-gap-grew-4-7x-while-enrollment-doubled-showing-scale-worsens-overpayment-not-improves-it.md
@@ -0,0 +1,33 @@
+---
+type: claim
+domain: health
+description: "Federal overpayment to MA increased from $18B (2015) to $84B (2025) while enrollment only doubled, indicating per-person overpayment is accelerating despite scale"
+confidence: proven
+source: "Kaiser Family Foundation, Medicare Advantage in 2025: Enrollment Update and Key Trends"
+created: 2025-07-24
+---
+
+# Medicare Advantage spending gap grew 4.7x while enrollment doubled showing scale worsens overpayment not improves it
+
+The federal government paid $84 billion more for Medicare Advantage enrollees in 2025 than it would have paid for equivalent beneficiaries in traditional fee-for-service Medicare—a 20% per-person premium. This spending gap has grown 4.7x since 2015, when the overpayment was $18 billion, while enrollment only doubled (from ~16M to 34M). The per-person overpayment has increased even as the program scaled.
+
+This trajectory contradicts the theory that MA plans would reduce costs through care coordination and efficiency gains. Instead, scale is amplifying the overpayment problem. The spending gap is growing faster than enrollment, indicating that either risk adjustment gaming is becoming more sophisticated, or MA plans are successfully lobbying for higher benchmark payments, or both.
+
+The $84B annual overpayment represents a massive subsidy to the managed care industry—larger than the entire NIH budget ($47B in 2024). This capital is flowing to companies like UnitedHealth Group and Humana rather than being available for other healthcare priorities or deficit reduction. The spending dynamics are particularly significant given regulatory efforts like [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring]], which suggests CMS recognizes the overpayment mechanism but incremental regulatory fixes have not closed the gap.
+
+## Evidence
+- 2025 overpayment: $84B (20% per-person premium vs FFS)
+- 2015 overpayment: $18B
+- Growth: 4.7x increase in spending gap
+- Enrollment growth: ~2x (16.2M in 2015 → 34.1M in 2025)
+- Spending gap growing faster than enrollment indicates per-person overpayment is increasing, not decreasing
+
+---
+
+Relevant Notes:
+- [[CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring]]
+- [[Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening]]
+- [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
+
+Topics:
+- [[domains/health/_map]]
diff --git a/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md b/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md
index 7cae923d2..34d378a70 100644
--- a/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md	
+++ b/domains/health/the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md	
@@ -285,6 +285,12 @@ Healthcare is the clearest case study for TeleoHumanity's thesis: purpose-driven
 
 PACE provides the most comprehensive real-world test of the prevention-first attractor model: 100% capitation, fully integrated medical/social/psychiatric care, continuous monitoring of a nursing-home-eligible population, and 8-year longitudinal data (2006-2011). Yet the ASPE/HHS evaluation reveals that PACE does NOT reduce total costs—Medicare capitation rates are equivalent to FFS overall (with lower costs only in the first 6 months post-enrollment), while Medicaid costs are significantly HIGHER under PACE. The value is in restructuring care (community vs. institution, chronic vs. acute) and quality improvements (significantly lower nursing home utilization across all measures, some evidence of lower mortality), not in cost savings. This directly challenges the assumption that prevention-first, integrated care inherently 'profits from health' in an economic sense. The 'flywheel' may be clinical and social value, not financial ROI. If the attractor state requires economic efficiency to be sustainable, PACE suggests it may not be achievable through care integration alone.
 
+
+### Additional Evidence (challenge)
+*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
+
+The Medicare Advantage trajectory challenges the prevention-first attractor thesis. MA enrollment crossed 50% in 2023 and reached 54% by 2025, with CBO projecting 64% by 2034. This represents the largest-scale implementation of aligned payment (capitation) in US healthcare. However, federal spending on MA is $84B more than fee-for-service equivalent (20% per-person premium), and this overpayment gap has grown 4.7x since 2015 while enrollment only doubled. The spending gap is accelerating, not closing. Additionally, the fastest-growing segment is Chronic-condition SNPs (71% growth 2024-2025), indicating the system is optimizing for chronic disease management, not prevention. The MA market structure—with UHG and Humana controlling 46% of enrollment—suggests oligopoly rent extraction rather than competitive efficiency gains. If aligned payment were driving prevention-first care, we would expect costs to converge with or fall below FFS, not diverge at an accelerating rate.
+
 ---
 
 Relevant Notes:
diff --git a/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md b/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md
index eb54caa1d..3d2767a1e 100644
--- a/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md	
+++ b/domains/health/value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md	
@@ -23,6 +23,12 @@ The Making Care Primary model's termination in June 2025 (after just 12 months,
 
 PACE represents the extreme end of value-based care alignment—100% capitation with full financial risk for a nursing-home-eligible population. The ASPE/HHS evaluation shows that even under complete payment alignment, PACE does not reduce total costs but redistributes them (lower Medicare acute costs in early months, higher Medicaid chronic costs overall). This suggests that the 'payment boundary' stall may not be primarily a problem of insufficient risk-bearing. Rather, the economic case for value-based care may rest on quality/preference improvements rather than cost reduction. PACE's 'stall' is not at the payment boundary—it's at the cost-savings promise. The implication: value-based care may require a different success metric (outcome quality, institutionalization avoidance, mortality reduction) than the current cost-reduction narrative assumes.
 
+
+### Additional Evidence (extend)
+*Source: [[2025-07-24-kff-medicare-advantage-2025-enrollment-update]] | Added: 2026-03-12 | Extractor: anthropic/claude-sonnet-4.5*
+
+Medicare Advantage represents the largest-scale implementation of full-risk value-based care, with 34.1M beneficiaries (54% of Medicare) enrolled in capitated plans as of 2025. This is full risk, not partial—MA plans bear 100% of the cost variance. However, the financial outcomes contradict the value-based care efficiency thesis: federal spending on MA is $84B higher than fee-for-service equivalent (20% per-person premium), and this gap has grown 4.7x since 2015 while enrollment doubled. The MA experience suggests that even at full risk and massive scale, the payment model alone does not drive cost reduction. Instead, the risk-adjustment system creates incentives for diagnosis coding optimization (upcoding) that may overwhelm care delivery efficiency gains. This provides a crucial real-world test case: when 54% of a major insurance program is at full risk, costs increased rather than decreased relative to FFS.
+
 ---
 
 Relevant Notes:
diff --git a/inbox/archive/2025-07-24-kff-medicare-advantage-2025-enrollment-update.md b/inbox/archive/2025-07-24-kff-medicare-advantage-2025-enrollment-update.md
index 303b9f5a9..083207f5f 100644
--- a/inbox/archive/2025-07-24-kff-medicare-advantage-2025-enrollment-update.md
+++ b/inbox/archive/2025-07-24-kff-medicare-advantage-2025-enrollment-update.md
@@ -7,9 +7,15 @@ date: 2025-07-24
 domain: health
 secondary_domains: []
 format: data
-status: unprocessed
+status: processed
 priority: high
 tags: [medicare-advantage, enrollment, market-concentration, market-share, kff]
+processed_by: vida
+processed_date: 2026-03-11
+claims_extracted: ["medicare-advantage-crossed-majority-enrollment-in-2023-marking-structural-transformation-from-public-to-managed-care.md", "medicare-advantage-market-is-an-oligopoly-with-unitedhealth-and-humana-controlling-46-percent-despite-nominal-plan-choice.md", "medicare-advantage-spending-gap-grew-4-7x-while-enrollment-doubled-showing-scale-worsens-overpayment-not-improves-it.md", "chronic-condition-special-needs-plans-grew-71-percent-in-one-year-indicating-explosive-demand-for-specialized-disease-management.md"]
+enrichments_applied: ["Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening.md", "the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness.md", "value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk.md"]
+extraction_model: "anthropic/claude-sonnet-4.5"
+extraction_notes: "Four new claims extracted covering MA's majority-enrollment inflection point, oligopoly market structure, accelerating spending gap, and C-SNP explosive growth. Three enrichments: extending Devoted competitive context, challenging the prevention-first attractor thesis with MA overpayment data, and extending the value-based care payment boundary claim with full-risk MA outcomes. The spending gap acceleration (4.7x growth while enrollment doubled) is the key structural insight—scale is making the overpayment problem worse, not better. C-SNP 71% growth connects to metabolic epidemic and chronic disease management demand."
 ---
 
 ## Content
@@ -79,3 +85,14 @@ tags: [medicare-advantage, enrollment, market-concentration, market-share, kff]
 PRIMARY CONNECTION: [[the healthcare attractor state is a prevention-first system where aligned payment continuous monitoring and AI-augmented care delivery create a flywheel that profits from health rather than sickness]]
 WHY ARCHIVED: Essential market structure data — the enrollment trajectory and concentration metrics ground claims about where the US healthcare system is actually heading vs. where theory says it should go.
 EXTRACTION HINT: The spending gap growing 4.7x while enrollment only doubled is the key structural insight — scale is making the overpayment problem worse, not better.
+
+
+## Key Facts
+- MA enrollment trajectory: 7.6M (19%) in 2007 → 10.8M (25%) in 2010 → 16.2M (32%) in 2015 → 23.8M (42%) in 2020 → 30.8M (51%) in 2023 → 32.8M (54%) in 2024 → 34.1M (54%) in 2025
+- CBO projects 64% MA penetration by 2034
+- 2025 market share: UnitedHealth 9.9M (29%), Humana 5.7M (17%), CVS/Aetna 4.1M (12%), Elevance 2.2M (7%), Kaiser 2.0M (6%), Others 10.3M (30%)
+- Plan type distribution: Individual 21.2M (62%), SNPs 7.3M (21%), Employer/union 5.7M (17%)
+- SNP breakdown: D-SNPs 6.1M (83%), C-SNPs 1.2M (16%), I-SNPs 115K (2%)
+- Average beneficiary has 9 parent organization options; 36% have 10+ options
+- 815 counties (26%) have 75%+ enrollment concentration in UHG + Humana
+- Employer/union group plans: first year of flat growth in ~10 years